Celldex Therapeutics, Inc.

CLDX13 Dec 2024
Healthcare
$26.78
-0.02 (-2.07%)
Lowest Today
$26.2
Highest Today
$27.16
Today’s Open
$26.78
Prev. Close
$27.01
52 Week High
$53.18
52 Week Low
$22.93
To Invest in Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

Healthcare
CLDX13 Dec 2024
-0.02 (-2.07%)
1M
3M
6M
1Y
5Y
Low
$26.2
Day’s Range
High
$27.16
26.2
52 Week Low
$22.93
52-Week Range
52 Week High
$53.18
22.93
1 Day
-
1 Week
-1.08%
1 month return
-1.34%
3 month return
-40.03%
6 month return
-27.33%
1 Year return
-23.73%
3 Years return
-30.91%
5 Years return
+1125.92%
10 Years return
-
Institutional Holdings
Wellington Management Company LLP
13.93
FMR Inc
9.08
BlackRock Inc
7.07
Vanguard Health Care Inv
6.84
Vanguard Group Inc
5.83
Kynam Capital Management, LP
5.21
Eventide Asset Management, LLC
5.02

Market Status

Fundamentals
Market Cap
1791.96 mln
PB Ratio
2.24
PE Ratio
0
Enterprise Value
1005.87 mln
Total Assets
465.63 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Organisation
Celldex Therapeutics, Inc.
Employees
160
Industry
Biotechnology
CEO
Mr. Anthony S. Marucci M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step